2021
DOI: 10.1007/s11033-021-06706-1
|View full text |Cite
|
Sign up to set email alerts
|

Crosslink between p53 and metastasis: focus on epithelial–mesenchymal transition, cancer stem cell, angiogenesis, autophagy, and anoikis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(11 citation statements)
references
References 76 publications
0
11
0
Order By: Relevance
“…P53 (TP53), as a tumor suppressor, is thought to be the most frequently mutated gene in cancer cells. There is increasing evidence that mutated p53 enhances tumor metastasis and affects EMT processes [139]. Moreover, a large number of recent studies have shown that p53 signaling plays a role in regulating the EMT process in lung cancer [140][141][142][143].…”
Section: Other Signaling Pathwaysmentioning
confidence: 99%
“…P53 (TP53), as a tumor suppressor, is thought to be the most frequently mutated gene in cancer cells. There is increasing evidence that mutated p53 enhances tumor metastasis and affects EMT processes [139]. Moreover, a large number of recent studies have shown that p53 signaling plays a role in regulating the EMT process in lung cancer [140][141][142][143].…”
Section: Other Signaling Pathwaysmentioning
confidence: 99%
“…Dysregulations of the TME contributing to the angiogenic switch have been linked to distinct mechanisms including anomalous expression levels of HIF-1, pro-angiogenic factors VEGF and bFGF as well as anti-angiogenic factors such as thrombospondin-1 (TSP-1) ( 83 , 84 ). The tumour suppressor gene p53 regulates these factors and mediates cellular functions such as apoptosis, DNA repair, cell cycle development and angiogenesis inhibition ( 83 ).…”
Section: Regulating Genes Of the Tumour Vasculaturementioning
confidence: 99%
“…Therefore, p53 mutations may lead to both increased HIF-1α and HIF-1β expression, thereby promoting angiogenesis by upregulating factors such as VEGF ( 86 ). Furthermore, p53 mutations have also been demonstrated to upregulate VEGF expression in human colon, bladder, and breast cancer surgical specimens as p53 acts directly on the VEGF promoter region ( 44 , 84 ).…”
Section: Regulating Genes Of the Tumour Vasculaturementioning
confidence: 99%
See 1 more Smart Citation
“…Imbalance of angiogenic and angiostatic markers that forms pathologic angiogenesis supplies the vital need of any growing malignant tissue. Compensatory mechanisms within non-small-cell lung carcinoma (NSCLC) overexpress endothelial growth factor (VEGF) and its receptor (VEGFR-2) that are the major responsible for pathologic angiogenic surge within the tumor [3] . EGF (Epidermal growth factor) which stabilizes hypoxia-inducible factor (HIF) leads to more angiogenesis transcription, cancer cell division and progression [4] .…”
Section: Introductionmentioning
confidence: 99%